SCHEMBL2641805

SCHEMBL2641805

CCCCCCN(C(=O)O)C(CC)N(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 3/20 0.39
DNM1 Q05193 3/20 0.39
GGPS1 O95749 3/20 0.38
KDM5A P29375 1/20 0.37
KDM4C Q9H3R0 1/20 0.37
PHF8 Q9UPP1 1/20 0.37
GPR84 Q9NQS5 6/20 0.36
PPARG P37231 6/20 0.36
PPARD Q03181 6/20 0.36
PPARA Q07869 6/20 0.36
HDAC11 Q96DB2 5/20 0.36
TSHR P16473 4/20 0.36
ALDH1A1 P00352 2/20 0.36
TLR2 O60603 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
FABP4 P15090 2/20 0.36
PTPN1 P18031 2/20 0.36
SLC22A6 Q4U2R8 1/20 0.36
SLC22A8 Q8TCC7 1/20 0.36
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1759008 0.77 EPHX2 (0.54) EPHX2GPR84PPARGPPARDPPARA
SCHEMBL6251336 0.73 GPR84 (0.46) GPR84PPARDFFAR1FFAR4
SCHEMBL29201414 0.73 MAPT (0.44) EPHX2GPR84PPARGPPARDPPARA
SCHEMBL20590751 0.72 DNM1 (0.48) DNM1GGPS1TSHRALDH1A1
SCHEMBL11355835 0.71 EPHX2 (0.42) EPHX2DNM1GPR84PPARGPPARD
SCHEMBL15225281 0.71 FAAH (0.40) EPHX2GPR84PPARGPPARDPPARA
SCHEMBL15224882 0.71 FAAH (0.40) EPHX2GPR84PPARGPPARDPPARA
SCHEMBL1416635 0.71 EPHX1 (0.43) EPHX2GPR84PPARGPPARDPPARA
SCHEMBL1416748 0.71 EPHX1 (0.43) EPHX2GPR84PPARGPPARDPPARA
SCHEMBL15224740 0.71 FAAH (0.40) EPHX2GPR84PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2569276-A1 NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOF Protiva Biotherapeutics Inc. (CA) 2013-03-20 EP disclosed
WO-2011141705-A1 NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOF PROTIVA BIOTHERAPEUTICS, INC. (CA) 2011-11-17 WO disclosed